Camp4 Therapeutics Corp

Camp4 Therapeutics Corp.

Biotechnology • Healthcare • Cambridge, MA, United States • CAMP (NGM)

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

617 651 8867 One Kendall Square, Cambridge, MA 02139, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Yahoo Finance • Sep 25
CAMP4 Therapeutics prices $30 million common stock offering - Investing.com
Investing.com • Dec 18
Camp4 Therapeutics Stock Rockets 108% With 6-Day Winning Streak - Trefis
Trefis • Dec 16
GSK and CAMP4 Partner to Advance RNA-Targeting Therapeutics - BioPharm International
BioPharm International • Dec 19
Ropes & Gray Advised CAMP4 Therapeutics in $30 Million Public Offering - Ropes & Gray LLP
Ropes & Gray LLP • Dec 19

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Camp4 Therapeutics Corp had layoffs?
No layoff events have been recorded for Camp4 Therapeutics Corp in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Camp4 Therapeutics Corp have?
Camp4 Therapeutics Corp has approximately 55 employees.
What industry is Camp4 Therapeutics Corp in?
Camp4 Therapeutics Corp operates in the Biotechnology industry, within the Healthcare sector.
Is Camp4 Therapeutics Corp a publicly traded company?
Yes, Camp4 Therapeutics Corp is publicly traded under the ticker symbol CAMP on the NGM. The company has a market capitalization of approximately $0.31 billion.
Where is Camp4 Therapeutics Corp headquartered?
Camp4 Therapeutics Corp is headquartered in Cambridge, MA, United States at One Kendall Square, Cambridge, MA 02139, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.